The Neurochemistry of Sleep and Wakefulness

Basic Neurochemistry

Volumn , Issue , 2012, Pages 982-999

  Baghdoyan, Helen A ^a   Lydic, Ralph ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867060212     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374947-5.00057-2     Document Type: Chapter

References (114)

1. Alam M.A., Mallick B.N. Glutamic acid stimulation of the perifornical-lateral hypothalamic area promotes arousal and inhibits non-REM/REM sleep. Neuroscience Letters 2008, 439:281-286.
2. Basheer R., Strecker R.E., Thakkar M.M., McCarley R.W. Adenosine and sleep-wake regulation. Progress in Neurobiology 2004, 73:379-396.
3. Benedetti F., Smeraldi E. Neuroimaging and genetics of antidepressant response to sleep deprivation: Implications for drug development. Current Pharmaceutical Design 2009, 15:2637-2649.
4. Berridge C.W. Noradrenergic modulation of arousal. Brain Research Reviews 2008, 58:1-17.
5. Brevig H.N., Baghdoyan H.A. Neurotransmitters and neuromodulators regulating sleep and wakefulness. Encyclopedia of behavioral neuroscience 2010, 456-463. Elsevier, Oxford. G.F. Koob, M. Le Moal, R.F. Thompson (Eds.).
6. Brown E.N., Lydic R., Schiff N.D. General anesthesia, sleep, and coma. The New England Journal of Medicine 2010, 363:2638-2650.
7. Burmeister J.J., Pomerleau F., Huettl P., Gash C.R., Werner C.E., Bruno J.P., et al. Ceramic-based multisite microelectrode arrays for simultaneous measures of choline and acetylcholine in CNS. Biosensors & Bioelectronics 2008, 23:1382-1389.
8. Carter L.P., Koek W., France C.P. Behavioral analyses of GHB: Receptor mechanisms. Pharmacology & Therapeutics 2009, 121:100-114.
9. Chase M.H., Monoson R., Watanabe K., Babb M.I. Somatic reflex response-reversal of reticular origin. Experimental Neurology 1976, 50:561-567.
10. Chaudhuri K.R., Logishetty K. Dopamine receptor agonists and sleep disturbances in Parkinson's disease. Parkinsonism & Related Disorders 2009, 15(Suppl. 4):S101-S104.
11. Chhangani B.S., Roehrs T.A., Harris E.J., Hyde M., Drake C., Hudgel D.W., et al. Pain sensitivity in sleepy pain-free normals. Sleep 2009, 32:1011-1017.
12. Cirelli C., Tononi G. Is sleep essential?. PLoS Biology 2008, 6:3216.
13. 2A agonist into the pontine reticular formation of C57BL/6J mouse increases pontine acetylcholine release and sleep. Journal of Neurochemistry 2006, 96:1750-1759.
14. Sleep disorders and sleep deprivation: An unmet public health problem 2006, National Academies Press, Washington, D.C. H.R. Colten, B.M. Altevogt (Eds.).
15. Dash M.B., Douglas C.L., Vyazovshiy V.V., Cirelli C., Tononi G. Long-term homeostasis of extracellular glutamate in the rat cerebral cortex across sleep and waking states. Journal of Neuroscience 2009, 29:620-629.
16. Datta S. Cellular and chemical neuroscience of mammalian sleep. Sleep Medicine 2010, 11:431-440.
17. Datta S., MacLean R.R. Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: Reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence. Neuroscience and Biobehavioral Reviews 2007, 31:775-824.
18. de Lecea L. A decade of hypocretins: Past, present and future of the neurobiology of arousal. Acta Physiologica 2010, 198:203-208.
19. Dworak M., McCarley R.W., Kim T., Kalinchuck A.V., Basheer R. Sleep and brain energy levels: ATP changes during sleep. Journal of Neuroscience 2010, 30:9007-9016.
20. Eisenach J.C., Rauck R.L., Curry R. Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain. Pain 2003, 105:65-70.
21. Fava M., McCall W.V., Krystal A., Wessell T., Rubens R., Caron J., et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biological Psychiatry 2006, 59:1052-1060.
22. Ferini-Strambi L., Manconi M. Treatment of restless legs syndrome. Parkinsonism & Related Disorders 2009, 15(Suppl. 4):S65-S70.
23. Fink K.B., Göthert M. 5-HT receptor regulation of neurotransmitter release. Pharmacological Reviews 2007, 59:360-417.
24. A receptors in the pontine reticular formation of C57BL/6J mouse modulate neurochemical, electrographic, and behavioral phenotypes of wakefulness. Journal of Neuroscience 2010, 30:12301-12309.
25. Friedman E.B., Sun Y., Moore J.T., Hung H.-T., Meng Q.C., Perera P., et al. A conserved behavioral state barrier impedes transitions between anesthetic-induced unconsciousness and wakefulness: Evidence for neural inertia. PLoS One 2010, 5:e11903.
26. Fronczek R., Baumann C.R., Lammers G.J., Bassetti C.L., Overeem S. Hypocretin/orexin disturbances in neurological disorders. Sleep Medicine Reviews 2009, 13:9-22.
27. Halassa M.M., Fellin T., Haydon P.G. Tripartite synapses: Roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology 2009, 57:343-346.
28. Halassa M.M., Florian C., Fellin T., Munoz J.R., Lee S.-Y., Abel T., et al. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 2009, 61:213-219.
29. Hambrecht-Wiedbusch V.S., Gauthier E.A., Baghdoyan H.A., Lydic R. Benzodiazepine receptor agonists cause drug-specific and state-specific alterations in EEG power and acetylcholine release in rat pontine reticular formation. Sleep 2010, 33:909-918.
30. Harris R.E., Sundgren P.C., Craig A.D., Kirshenbaum E., Sen A., Napadow V., et al. Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis and Rheumatism 2009, 60:3146-3152.
31. Hass H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiological Reviews 2008, 88:1183-1241.
32. Hassani O.K., Lee M.G., Henny P., Jones B.E. Discharge profiles of identified GABAergic in comparison to cholinergic and putative glutamatergic basal forebrain neurons across the sleep-wake cycle. Journal of Neuroscience 2009, 29:11828-11840.
33. Henny P., Jones B.E. Innervation of orexin/hypocretin neurons by GABAergic, glutamatergic, or cholinergic basal forebrain terminals evidenced by immunostaining for presynaptic vesicular transporter and postsynaptic scaffolding proteins. Journal of Comparative Neurology 2006, 499:645-661.
34. Henny P., Jones B.E. Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamateric inputs to pyramidal cells or interneurons. The European Journal of Neuroscience 2008, 27:654-670.
35. Herring W.J., Budd K.S., Hutzelmann J., Snyder E., Snavely D., Liu K., et al. Efficacy and tolerability of the dual orexin receptor antagonist MK-4305 in patients with primary insomnia: randomized, controlled, adaptive crossover polysomnography study. Sleep 2010, 33(Abstr Suppl):A199.
36. Hobson J.A. Consciousness 1999, Scientific American Library, New York.
37. Hobson J.A., Steriade M. The neuronal basis of behavioral state control. Handbook of physiology-the nervous system 1986, Vol. 4:297-338. American Physiological Society, Bethesda, MD.
38. 2A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats. Journal of Neurochemistry 2005, 92:1542-1549.
39. Huang Z.-L., Urade Y., Hayaishi O. Prostaglandins and adenosine in the regulation of sleep and wakefulness. Current Opinion in Pharmacology 2007, 7:33-38.
40. Jasper H.H., Tessier J. Acetylcholine liberation from cerebral cortex during paradoxical (REM) sleep. Science 1971, 172:601-602.
41. John J., Ramanathan L., Siegel J.M. Rapid changes in glutamate levels in the posterior hypothalamus across sleep-wake states in freely behaving rats. American Journal of Physiology. Regulatory. Integrative and Comparative Physiology 2008, 295:R2041-R2049.
42. Jones B.E. From waking to sleeping: Neuronal and chemical substrates. Trends in Pharmacological Sciences 2005, 26:578-586.
43. Jouvet M. Biogenic amines and the states of sleep. Science 1969, 163:32-41.
44. Jouvet M. Sleep and serotonin: An unfinished story. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 1999, 21:24S-27S.
45. Kaneko T., Itoh K., Shigemoto R., Mizuno N. Glutaminase-like immunoreactivity in the lower brainstem and cerebellum of the adult rat. Neuroscience 1989, 32:79-98.
46. Kelz M.B., Sun Y., Chen J., Cheng Meng Q., Moore J.T., Veasey S.C., et al. An essential role for orexins in emergence from general anesthesia. Proceedings of the National Academy of Sciences of the United States of America 2008, 1309-1314.
47. Kilduff T.S., Peyron C. The hypocretin/orexin ligand-receptor system: Implications for sleep and sleep disorders. Trends in Neurosciences 2000, 23:359-365.
48. Kiyashchenko L.I., Mileykovskiy B.Y., Maidment N., Lam H.A., Wu M.F., John J., et al. Release of hypocretin (orexin) during waking and sleep states. Journal of Neuroscience 2002, 22:5282-5286.
49. Principles and practice of sleep medicine 2011, Elsevier, St. Louis. 5th ed. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
50. Krystal A.D., Durrence H.H., Scharf M., Jochelson P., Rogowski R., Ludington E., et al. Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia. Sleep 2010, 33:1553-1561.
51. Landolt H.-P. Sleep homeostasis: A role for adenosine in humans?. Biochemical Pharmacology 2008, 75:2070-2079.
52. 2A/2C receptors: Mutual improvement of sleep, cognition and mood?. The European Journal of Neuroscience 2009, 29:1795-1809.
53. Sleep and pain 2007, IASP, Seattle. G. Lavigne, B.J. Sessle, M. Choinière, P.J. Soja (Eds.).
54. Lee M.G., Hassani O.K., Jones B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. Journal of Neuroscience 2005, 25:6716-6720.
55. Lenfant, C. (2003). 2003 National sleep disorders research plan. In: National Institutes of Health. http://www.nhlbi.nih.gov/health/prof/sleep/res_plan/preface.html.
56. Li Y., Gao X.-B., Sakurai T., van den Pol A.N. Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron-a potential mechanism for orchestrating the hypothalamic arousal system. Neuron 2002, 36:1169-1181.
57. Liang C.L., Marks G.A. A novel GABAergic afferent input to the pontine reticular formation: The mesopontine GABAergic column. Brain Research 2009, 1297:32-40.
58. Liu Z.-W., Gao X.-B. Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: A possible sleep-promoting effect. Journal of Neurophysiology 2007, 97:837-848.
59. López-Rodríguez F., Kohlmeier K., Morales F.R., Chase M.H. State dependency of the effects of microinjection of cholinergic drugs into the nucleus pontis oralis. Brain Research 1994, 649:271-281.
60. Lydic R., Baghdoyan H.A. Ketamine and MK-801 decrease acetylcholine release in the pontine reticular formation, slow breathing, and disrupt sleep. Sleep 2002, 25:615-620.
61. Lydic R., Baghdoyan H.A. Sleep, anesthesiology, and the neurobiology of arousal state control. Anesthesiology 2005, 103:1268-1295.
62. Lydic R., Baghdoyan H.A. Neurochemical mechanisms mediating opioid-induced REM sleep disruption. Sleep and pain 2007, 99-122. IASP, Seattle. G. Lavigne, B.J. Sessle, M. Choinière, P.J. Soja (Eds.).
63. Lydic R., Baghdoyan H.A. Acetylcholine modulates sleep and wakefulness: A synaptic perspective. Neurochemistry of sleep and wakefulness 2008, 109-143. Cambridge University Press, New York. J.M. Monti, S.R. Pandi-Perumal, C.M. Sinton (Eds.).
64. Mamelak M. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate. Progress in Neurobiology 2009, 89:193-219.
65. Manfridi A., Brambilla D., Mancia M. Stimulation of NMDA and AMPA receptors in the rat nucleus basalis of Meynert affects sleep. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 1999, 277:R1488-R1492.
66. Marks G.A., Shaffery J.P., Speciale S.G., Birabil C.G. Enhancement of rapid eye movement sleep in the rat by actions at A1 and A2a adenosine receptor subtypes with a differential sensitivity to atropine. Neuroscience 2003, 116:913-920.
67. McKenna J.T., Tartar J.L., Ward C.P., Thakkar M.M., Cordeira J.W., McCarley R.W., et al. Sleep fragmentation elevates behavioral, electrographic and neurochemical measures of sleepiness. Neuroscience 2007, 146:1462-1473.
68. Mileykovskiy B.Y., Kiyashchenko L.I., Siegel J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005, 46:787-798.
69. Monti J.M., Monti D. The involvement of dopamine in the modulation of sleep and waking. Sleep Medicine Reviews 2007, 11:113-133.
70. Moore J.T., Kelz M.B. Opiates, sleep and pain. The adenosinergic link. Anesthesiology 2009, 111:1175-1176.
71. Nelson A.M., Battersby A.S., Baghdoyan H.A., Lydic R. Opioid induced decreases in rat brain adenosine levels are reversed by inhibiting adenosine deaminase. Anesthesiology 2009, 111:1327-1333.
72. NIH Consensus Panel Report National Institutes of Health state of the science conference statement: Manifestations and management of chronic insomnia in adults. Sleep 2005, 28:1049-1057.
73. Nishino S., Okuro M., Kotorii N., Anegawa E., Ishimaru Y., Matsumura M., et al. Hypocretin/orexin and narcolepsy: New basic and clinical insights. Acta Physiologica 2010, 198:209-222.
74. Nofzinger E.A. Neuroimaging and sleep medicine. Sleep Medicine Reviews 2005, 9:157-172.
75. Nofzinger E.A. Functional neuroimaging of sleep disorders. Current Pharmaceutical Design 2008, 14:3417-3429.
76. 1 receptors and promotes non-rapid eye movement sleep. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:19992-19997.
77. Pace-Schott E.F., Hobson J.A. The neurobiology of sleep: Genetics, cellular physiology, and subcortical networks. Nature Reviews Neuroscience 2002, 3:591-605.
78. 3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochemical Pharmacology 2007, 73:1157-1171.
79. Porkka-Heiskanen T., Strecker R.E., McCarley R.W. Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: An in vivo microdialysis study. Neuroscience 2000, 99:507-517.
80. Robinson D.L., Hermans A., Seipel A.T., Wightman R.M. Monitoring rapid chemical communication in the brain. Chemical Reviews 2008, 108:2554-2584.
81. Rodrigo-Angulo M.L., Heredero S., Rodríguez-Veiga E., Reinoso-Suárez F. GABAergic and non-GABAergic thalamic, hypothalamic and basal forebrain projections to the ventral oral pontine reticular formation: Their implication in REM sleep modulation. Brain Research 2008, 1210:116-125.
82. Roth T., Lines C., Vandormael K., Ceesay P., Anderson D., Snavely D. Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with primary insomnia: Results from two randomized, controlled, 3-month studies. Journal of Clinical Sleep Medicine 2010, 6:30-40.
83. Roth T., Rogowski R., Hull S., Schwartz H., Koshorek G., Corser B., et al. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia. Sleep 2007, 30:1555-1561.
84. Sakurai T. The neural circuit of orexin (hypocretin): Maintaining sleep and wakefulness. Nature Reviews Neuroscience 2007, 8:171-181.
85. Sakurai T., Mieda M., Tsujino N. The orexin system: Roles in sleep/wake regulation. Annals of the New York Academy of Sciences 2010, 1200:149-161.
86. 3 receptor antagonists go to clinics. Biological & Pharmaceutical Bulletin 2008, 31:2163-2181.
87. Saul S. Record sales of sleeping pills are causing worries. New York Times 2006.
88. Scharf M.T., Naidoo N., Zimmerman J.E., Pack A.I. The energy hypothesis of sleep revisited. Progress in Neurobiology 2008, 86:264-280.
89. Sebastião A.M., Ribeiro J.A. Adenosine receptors and the central nervous system. Adenosine receptors in health and disease 2009, 471-534. Springer, Berlin. C.N. Wilson, S.J. Mustafa (Eds.).
90. Siegel J.M. Sleep viewed as a state of adaptive inactivity. Nature Reviews Neuroscience 2009, 10:747-753.
91. Stenberg D. Neuroanatomy and neurochemistry of sleep. Cellular and Molecular Life Sciences 2007, 64:1187-1204.
92. Stepanski E.J. The effect of sleep fragmentation on daytime function. Sleep 2002, 25:268-276.
93. Steriade M., McCarley R.W. Brain control of wakefulness and sleep 2005, Plenum, New York. 2nd ed.
94. Szymusiak R., Gvilia I., McGinty D. Hypothalamic control of sleep. Sleep Medicine 2007, 8:291-301.
95. Takahashi K., Lin J.-S., Sakai K. Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. Journal of Neuroscience 2006, 26:10292-10298.
96. 1 receptor agonist to the pontine reticular formation decreases acetylcholine release and increases anesthesia recovery time. Anesthesiology 2004, 98:912-920.
97. Thakkar M.M., Winston S., McCarley R.W. Orexin neurons of the hypothalamus express adenosine A1 receptors. Brain Research 2002, 944:190-194.
98. Thakkar M.M., Engemann S.C., Walsh K.M., Sahota P.K. Adenosine and the homeostatic control of sleep: Effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness. Neuroscience 2008, 153:875-880.
99. Torrealba F., Yanagisawa M., Saper C.B. Colocalization of orexin A and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 2003, 119:1033-1044.
100. Trenkwalder C., Paulus W. Restless legs syndrome: Pathophysiology, clinical presentation and management. Nature Reviews Neurology 2010, 6:337-346.
101. Tsujino N., Sakurai T. Orexin/hypocretin: A neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacological Reviews 2009, 61:162-176.
102. Ursin R. Serotonin and sleep. Sleep Medicine Reviews 2002, 6:57-69.
103. 2A receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal. Journal of Neuroscience 2009, 29:871-881.
104. Vanini G., Baghdoyan H.A., Lydic R. Relevance of sleep neurobiology for cognitive neuroscience and anesthesiology. Consciousness, awareness, and anesthesia 2010, 1-23. Cambridge University Press. G.A. Mashour (Ed.).
105. Vanini G., Watson C.J., Lydic R., Baghdoyan H.A. GABAergic neurotransmission in the pontine reticular formation modulates hypnosis, immobility, and breathing during isoflurane anesthesia. Anesthesiology 2008, 109:978-988.
106. Vanini, G., Baracy, C. R., Lydic, R., Baghdoyan, H.A. (2010b). GABA levels in cat basal forebrain and cortex are greater during non-rapid eye movement (NREM) sleep than during REM sleep and wakefulness. Society for Neuroscience Meeting Planner Online Program No.:798.1.
107. Vanini G., Torterolo P., Baghdoyan H.A., Lydic R. The shared circuits of sleep and anesthesia. The Neuroscientific Foundations of Anesthesiology 2011, 33-44. Oxford University Press, New York. G.A. Mashour, R. Lydic (Eds.).
108. Vanini G., Wathen B.L., Lydic R., Baghdoyan H.A. Endogenous GABA levels in the pontine reticular formation are greater during wakefulness than during rapid eye movement sleep. Journal of Neuroscience 2011, 31:2649-2656.
109. Wang H.-L., Morales M. Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. The European Journal of Neuroscience 2009, 29:340-358.
110. Watson C.J., Venton B.J., Kennedy R.T. In vivo measurements of neurotransmitters using microdialysis sampling. Analytical Chemistry 2006, 78:1391-1399.
111. Watson C.J., Baghdoyan H.A., Lydic R. Neuropharmacology of sleep and wakefulness. Sleep Medicine Clinical 2010, 5:513-528.
112. Wigren H.-K., Schepens M., Matto V., Stenberg D., Porkka-Heiskanen T. Glutamatergic stimulation of the basal forebrain elevates extracellular adenosine and increases the subsequent sleep. Neuroscience 2007, 147:811-823.
113. Xi M.C., Chase M.H. The injection of hypocretin-1 into the nucleus pontis oralis induces either active sleep or wakefulness depending on the behavioral state of the animal when it is administered. Sleep 2010, 33:1236-1243.
114. Zhang Y., Conklin D.R., Li X., Eisenach J.C. Intrathecal morphine reduces allodynia after peripheral nerve injury in rats via activation of a spinal A1 adenosine receptor. Anesthesiology 2005, 102:416-420.